Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and potential side effects of everolimus
(an experimental drug) on a person with Tuberous Sclerosis Complex who also has been
diagnosed with a brain tumor (astrocytoma)
The hypothesis is that the drug will cause the tumor size to decrease, and may have
beneficial activity separate from effects on tumors in patients.